Back to ERYP.PA
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
2
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Acute Lymphoblastic Leukemia, in Relapse
View Full LandscapeDrug Information
Target Indication
Acute Lymphoblastic Leukemia, in Relapse
Clinical Trial
NCT01518517Last updated: 2/14/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Regulatory Approvals
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts